Anupam Rasayan India has signed Memorandum of Understanding (MoU) with 3xper Innoventure, a subsidiary of Tube Investments of India, a leading business conglomerates of India for supply of targeted and identified new age pharma molecules. The identified products for Active Pharmaceutical Ingredients (API) will be developed under the CRAMS and CDMO models.
Anupam Rasayan India (ARIL) is one of the leading companies engaged in the custom synthesis (CSM) and manufacturing of specialty chemicals in India.